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Abstract
The recently published “COSMIN” guidelines aim to rate properties of outcome instruments and state two issues
with regard to responsiveness which is the instrument’s ability to detect change over time. These issues are
comparison of score changes with change of an external criterion using correlations and the judgement of
traditional methods as inappropriate. The latter are the “transition” concept, a global rating of change, and
parametric measures of responsiveness, for example, effect sizes. It can be shown that the methodology proposed
by the guidelines has important weaknesses and that denunciation of traditional methods is not appropriate. Some
claims of the guidelines about responsiveness do not match the demands of clinical reality and confront findings
of numerous epidemiological studies.
Instructions and demands of the COSMIN
guidelines
At the department of epidemiology and biostatistics,
University Medical Center, Amsterdam, NL, a group
recently established guidelines to assess and prove mea-
surement properties and qualities of self-assessed health
outcome instruments [1,2]. The criteria for the guide-
lines were established using the Delphi method [1].
However, it can be shown in the following that substan-
tial methods of methodological or empirical literature
were not consulted. For this reason, it is likely that a
debate on the conclusions and instructions will be
raised. In this COSMIN (COnsensus-based Standards
for selection of health Measurement INstruments)
checklist manual, the methodology to examine respon-
siveness, i.e. “the instrument’s ability to detect change
over time in the construct to be measured” gives the fol-
lowing instructions [1,2]:
Score changes over time as derived from the assess-
ment instruments should be compared and correlated to
those of a “gold-standard” or an “external criterion”,s e e
p .5o f[ 2 ] .I fn og o l d - s t a n d a r di sa v a i l a b l et h es c o r e
changes of an instrument under examination have to be
correlated to “changes in other variables, such as scores
on other instruments, or demographic or clinical vari-
ables”, see items 8-14, p.40/41 of [1]. This should be
done by hypotheses formulated a priori about the direc-
tion and magnitude of the score change correlations
[1,2]. This means that direct comparison of the score
changes of two or more instruments, as has been done
according to traditional concepts to date, is obsolete. In
particular, parameters like effect sizes (ES), standardized
response means (SRM), or Guyatt’s responsiveness ratio,
a n do t h e rw e l lk n o w np a r a m e t e r si nc o m m o nu s ea r e
“inappropriate” and should not be used to assess
responsiveness, see p. 42 of [1] and p. 6 of [2].
The issue of gold-standard or external criterion
With regard to these requirements and claims, the fol-
lowing comments can be made. In most cases of empiri-
cal research, neither a “gold-standard” nor an “external
criterion” exists. One example for that is the measure-
ment of pain since pain is a complex bio-psycho-social
sensation and is especially individual in terms of percep-
tion, processes, and coping. Although the COSMIN
authors admit that a gold-standard is generally impossi-
ble to find, they do not offer a solution for this problem,
see items 15-18, p. 42 of [1].
On p. 40 of the manual, it is stated that “sometimes, a
global rating scale of change was used to ask patients if
they considered themselves as changed on the con-
struct” - remark: to obtain an external criterion [1]. The
question about the global rating of change is the well-
known “transition” question. The concept was Correspondence: f.angst@rehaclinic.ch
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However, on p. 42 of the manual, it is stated: “some
authors have questioned the reliability and validity of
such retrospective measures of change [4]. Therefore,
this rating scale was not considered to be an appropriate
gold standard for assessing responsiveness. It could,
however, be considered a useful comparator instrument
in a construct approach” [1]. It remains unclear for the
reader whether the transition method is appropriate in
the absence of a gold-standard. If not this implies that
research over 20 years and hundreds of published stu-
dies that used the transition concept would become irre-
levant. Although the transition concept may have its
shortcomings it is the only one that is available to solve
this problem and it has been applied up to now despite
the criticism.
Responsiveness aims at detecting change over time in
the construct to be measured. When comparing instru-
ment 1 to instrument 2, the more responsive instrument
is more likely to detect changes over time than the
o t h e ro n e .T a k i n ga ne x a m p l e ,w eo n l yw a n tt ok n o w
whether camera 1 takes sharper/better contrasted pic-
tures (over time: as a film) than camera 2 to detect
objects. Two articles that tried to explain the COSMIN
rules demand that, in this case, the score change of
i n s t r u m e n t1( =a )m u s tb ec o m p a r e dt ot h a to fa n
external criterion/gold standard (= c) and then be
related to the change of instrument 2 (= b); see p. 5 of
[2] and the empirical example [5]. The differences of
these score changes to the score change of the external
criterion (c) will be (a-c) and (b-c). The difference
between these differences is (a-c)-(b-c) = a-b by the
well-know mathematical translation rule. Analogously,
the correlation of (a-c) to (b-c) is the correlation of a to
b. In both cases, the external criterion and its score
change (c) is not necessary. Likewise, what the picture/
objects are like in physical “reality” is not important -
nobody knows it - because our eye plus our optical cor-
tex depict only a part of the physical reality (= the exter-
nal criterion) and this varies from individual to
individual.
The issue of comparing responsiveness by
correlations
Further insight into the COSMIN concept is given by an
exemplary study on how to assess responsiveness [5]. In
this study, a number of predefined hypotheses were sta-
ted to test responsiveness/longitudinal construct validity.
The hypotheses compare correlations of score changes
between instruments. For example: “Correlation of
change on instrument 1/instrument 2 with change on
instrument 3 (= the first external criterion) is higher
than correlation with the global rating question (= the
transition question as second external criterion) by (an
expected correlation difference of) 0.1"; see table 2 of [5]
or p. 5 of [2]. In this example, 8 hypotheses were stated
for mobility of which 6 (75%) were refuted. This was
interpreted as poor responsiveness. 25-50% refuted
hypotheses means moderate, < 25% high responsiveness.
This example led to the following comments: The
kind, content, and number of the hypotheses are arbi-
trary. Comparing two instruments, the list of possible
hypotheses is almost indefinite depending on how much
detail is sought. This means that the proportion of
refuted hypotheses is arbitrary and is dependent on the
moment when the stating of hypotheses stopped. This
proportion is the basis for the categorized rating of
responsiveness, e.g. > 50% refuted hypotheses means
poor responsiveness. First, these thresholds are also
arbitrary and not empirically validated. Second, the
expected correlation difference of 0.1 is arbitrary, not
empirically validated and has no clinical importance.
These two problems are even explicitly stated in the dis-
cussion of the exemplary study [5].
Verification and falsification of hypotheses is only a qua-
litative, not a quantitative analysis as given by the concept
of ES or SRM. As a hypothetical example (to the exemp-
lary study) case 1 is that (score change) correlation of the
first instrument to the external criterion is 0.60 and 0.71
of the second instrument - the correlation difference is
0.11. Case 2 is that the correlation of the first instrument
is 0.01 and of the second instrument is 0.99 - the correla-
tion difference is 0.98. In both cases, the hypothesis,
namely, the correlations’ difference of 0.10 is true but the
different amount of the correlation differences is not rele-
vant when using the COSMIN concept as done in [5]. In
addition, the exemplary study which aimed to explain the
guidelines made use of the transition concept as an exter-
nal criterion [5]. But the transition concept has been
refused as an external criterion in the guidelines [1].
Finally, instrument 3 in that study was a questionnaire
which had not been longitudinally validated according to
the COSMIN principles before and can, consequently, not
be used as a valid external criterion [5].
The issue of traditional responsiveness measures
Responsiveness parameters such as ES, SRM etc. are
accepted worldwide and used in a large body of scienti-
fic literature as been shown below. Nowhere in the
manual do the authors give a detailed explanation or
arguments as to why these parameters are “inappropri-
ate"; see p. 42 of [1] and p. 6,7 of [2]. The reader may
find an implicit explanation in the statement that “these
measures are considered measures of the magnitude of
an intervention or the event, rather than measures of
the quality of the measurement instrument”, see p. 42 of
[1] and p. 6 of [2].
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measures at the same time points, in the same situation,
and to the same patients. Therefore, the “intervention”
and the “event” must be the same for both instruments
and differences of score changes, i.e. differences between
ESs and SRMs, must be caused by the differences in the
quality of the two instruments.
A sas e c o n dr e a s o n i n gc a nb ef o u n di nt h ee x e m p l a r y
study on p. 234 [5]: “Measures of treatment effects such
as effect sizes of the t-test statistic are in itself only use-
ful for interpretation of score changes, not for assessing
the responsiveness of a measure, because it will not be
possible to infer if a corresponding change in the con-
cept has taken place”.H o w e v e r ,i ti sn o tf u r t h e r
explained what “change in the concept” could take place
or what “infer” m e a n si nt h i sc o n t e x ta n dt h es e n c eo f
this statement remains unclear for the reader.
The concept of measuring change over time by ES (=
mean score change divided by standard deviation at
baseline) and related parameters was introduced by
Rosenthal and Kazis for the interpretation of changes in
health status as a result of decades of previous research
[6,7]. In particular, it has also been used to compare
responsiveness of two instruments. A short Pubmed
review (on 25/2/2011 with keywords: responsiveness and
(ES or SRM) reveals that the application of this concept
has been reported in 1,387 research articles. To label
that as “inappropriate” means to confront the rest of the
research world and to set aside the research efforts and
publications of decades. Moreover, all ongoing studies
designed on the basis of these concepts and assessment
strategies will not be able to publish their future respon-
siveness results. All currently used instruments that
involve testing of responsiveness by quantitative mea-
sures such as ES, SRM etc. could no longer be consid-
ered valid and all clinical studies that utilized these
instruments would have invalid results.
With regard to Guyatt’s responsiveness ratio being an
“inappropriate” measure, some of the members of the
COSMIN group, namely Terwee et al., published con-
trary statements in their paper entitled “Quality criteria
were proposed for measurement properties” in 2007 [8]:
“Responsiveness should therefore be tested by relating
the smallest detectable change to the minimal important
change. This approach is equalent to the Guyatt’s
responsiveness ratio, ...”.
Conclusions and implications for clinical practice
Clinical practice is confronted with the difficulty that
clinicians need to be able to comprehend and apply the
concepts of responsiveness of assessment instruments in
daily routine. ES and SRM are heuristic measures of
change and have found acceptance in science and clini-
cal practice over many years. The quantitative amount
of change is important for the clinician and should be
easy to comprehend. To obtain an overview and assess
proportions of correlation differences as proposed by
the COSMIN guidelines is difficult and not readily
accessible. It can be expected that many clinicians may
have difficulty understanding and applying this concept
and the methodology will be limited to a small circle of
researchers. Dogmatic introduction of the COSMIN
responsiveness guidelines at once, without transition
and without acceptance of concurrent concepts is likely
to result in low acceptance and marginal clinical
importance.
In summary, standardized rules to test instruments are
welcome in research. The COSMIN rules to examine
responsiveness leave many open questions. How can we
deal with the problems and contradictions described
above? It should be possible to reassess the “inappropri-
ateness” of the transition concept and of the parametric
measures (ES, SRM etc.) through detailed and balanced
arguments. The COSMIN concepts may have a supple-
mentary value when focussing on longitudinal construct
validity. For most clinicians, responsiveness is not (only)
a question of longitudinal validity - they simply wish to
find that instrument that more accuately detects
changes over time than the other by a quantitative mea-
sure - not more and not less. It should be possible to
take the positive properties of both concepts, the tradi-
tional and those of COSMIN, to find improved stan-
dards and to proceed according to the principle of “live
and let live”. If not, how shall we deal with the validity
and responsiveness findings of existing literature,
research, and clinical routine?
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In this piece, Dr Angst argues that some of the claims
of the COSMIN guidelines about responsiveness do not
match the demands of clinical reality and confront find-
ings of numerous epidemiological studies.
We thank Dr Angst for his interest in the COSMIN
checklist and we think he raises some relevant issues
concerning responsiveness. Before we give our reaction
to these issues, we would like to emphasize that the
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odological quality of studies on measurement properties.
It is not a checklist to assess the quality of a measure-
ment instrument. Furthermore, we think it is important
to mention that the COSMIN checklist was developed
in a Delphi study in which over 40 international experts
were involved. The members of the Steering Committee
did not have a vote in these Delphi rounds [9].
We do not agree with all issues raised by Angst. How-
ever, we might not have been clear enough in our man-
ual. Therefore, we would like to take the opportunity to
explain the viewpoints of COSMIN regarding respon-
siveness in more detail. Based on the remarks of dr
Angst we further clarified some issues in the COSMIN
manual [1].
In our response, we focus on four points which will
elucidate COSMIN’s ideas around responsiveness and
deal with the concerns of dr Angst:
Responsiveness is longitudinal validity and therefore
the assessment of responsiveness closely follows the way
in which validity of measurement instruments is
assessed.
A distinction should be made between the interpreta-
tion of changes in health status and responsiveness as a
measurement property of a measurement instrument.
The literature on responsiveness using effect sizes and
other “inappropriate measures” should not be thrown
away, but provides less evidence than previously
thought.
The COSMIN guidelines do not reject the “transition”
question, but recommend to test hypotheses about
expected relations with the “transition” question.
Responsiveness is longitudinal validity
Dr Angst argues that “For most clinicians, responsive-
ness is not (only) a question of longitudinal validity -
they simply wish to find that instrument that more
accurately detects changes over time than the other by a
quantitative measure”.A c c o r d i n gt oC O S M I N ,t h i si s
the same because accurate detection of change means
measuring the true amount of change, which is a matter
of longitudinal validity.
The COSMIN panel was very clear that responsive-
ness should be considered as longitudinal validity. If you
want to measure change, a valid instrument should truly
measure changes in the construct(s) it purports to mea-
sure. The only distinction between (construct and criter-
ion) validity and responsiveness is that validity concerns
the validity of single scores while responsiveness con-
cerns the validity of change scores. Consequently, the
COSMIN panel concluded that responsiveness should
be evaluated similarly as validity, i.e. by comparing
changes on the instrument with changes on the gold
standard, or - since often there is no gold standard - by
testing hypotheses e.g. about expected correlations with
changes in other measures, or expected differences in
changes between groups.
One of the most difficult tasks when testing hypoth-
esis, is formulating challenging hypotheses. By testing
hypotheses we aim to show that the instrument truly
measures changes in the construct(s) it purports to mea-
sure. In practice, this means that the instrument should
measure (changes in) the right construct(s) and not
(changes in) something else, but also that it should mea-
sure the right amount of change, i.e. it should not
under- or overestimate the real change in the construct
that has occurred. This latter aspect is often overlooked
in assessing responsiveness. In the COSMIN manual we
explain that specific hypotheses should therefore include
an expectation about the direction and magnitude of the
correlation between changes in the instrument under
study and changes in a comparator instrument, or an
expectation about differences in change scores on the
instrument between groups.
In one of the COSMIN articles [2], we provided some
examples of hypotheses based on one of our previous
studies [5]. We would like to emphasize that these
hypotheses were only used as examples. The COSMIN
panel considered it not possible to formulate standards
for the amount of hypotheses that need to be tested in a
construct validity study. This depends on the construct
to be measured and the content and measurement prop-
erties of the comparator instruments [1]. The definition
of criteria for good measurement properties was beyond
the scope of the COSMIN study.
Note that also for assessing validity we also have no
quantitative measures and we also test an arbitrary cho-
sen number of hypotheses. There is no criterion to
decide whether an instrument is valid or responsive.
Assessing validity or responsiveness is a continuous pro-
cess of accumulating evidence.
Distinction between the interpretation of changes in
health status and responsiveness as a measurement
property of a measurement instrument
Effect sizes and related parameters have been introduced
by Cohen [10] to provide a standardized measure of the
magnitude of an effect. These measures are used to
interpret changes in health status, or magnitudes of
treatment effects.
It is impossible to assess in one study both the treat-
ment effect and the responsiveness of measurement
instrument based on the same effect size. If the effect
size is zero, either the intervention has no effect or the
outcome measure is not responsive. If the effect size is
moderate, more conclusions are possible: either the
effect is moderate and the outcome measure is respon-
s i v e ,o rt h ee f f e c ti sl a r g eo rs m a l la n dt h eo u t c o m e
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is over- of underestimated by the instrument. So the
argument of the COSMIN panel is that the effect size
only has meaning as a measure of responsiveness if we
know (or assume) beforehand what the magnitude of the
effect of the intervention is. If, for example, we expect a
large effect of the intervention we can test the hypothesis
that the measurement instrument shows an effect size of
0.8 or higher. But if we expect a small effect of the inter-
vention, we would not expect such a high effect size.
This example shows that a high effect size does not
necessarily indicates a good responsiveness.
When several instruments are compared in the same
study, this could give evidence for the relative respon-
siveness of the instruments. But again, only if a hypoth-
esis is being tested including the expected magnitude of
the treatment effect. Let us propose that we have three
measurement instruments (A, B, and C), all measuring
the same construct. The intervention given is expected
to moderately affect the construct measured by the
three instruments. Results show that instrument A has
an effect size of 0.8, instrument B of 0.40 and instru-
ment C of 0.15. Based on our hypothesis of a moderate
effect we should conclude that instrument B appears to
best measure the construct of interest. Instrument A
seems to over-estimates the treatment effect (e.g.
because it shows change in persons who do not really
change), and instrument A seems to under-estimates it.
This example shows that it may not always be appropri-
ate to conclude that the instrument with the highest
effect size is the most responsive.
The literature on responsiveness using effect sizes and
other “inappropriate measures” should not be thrown
away, but provides less evidence than previously thought
In the previous paragraphs, we have tried to explain that
the COSMIN panel does not totally discard effect sizes
as parameters of responsiveness, but argues that it is
necessary to formulate and test hypotheses about the
magnitude of change that is to be expected from the
treatment. Many responsiveness studies, however, have
been published (and still are) in which an instrument
was considered responsive just because the effect size
w a sl a r g e rt h a n0 . 8 .T h i si sw h a tC O S M I Nc o n s i d e r s
inappropriate.
Note that COSMIN does not intend to set aside dec-
ades of research. Published studies do provide evidence
for responsiveness, but less than previously thought.
These studies can be included in systematic reviews of
measurement properties. However, it is then up to the
authors of the review to decide (in retrospect) whether
the results found are as could have been expected, tak-
ing the treatment, the construct to be measured, the
population etc. into account. This may, however, be
more difficult and more prone to bias than formulating
hypotheses before the data collection.
The COSMIN guidelines do not reject the “transition”
question, but recommend to test hypotheses about
expected relations with the “transition” question
We agree with dr Angst that there is no gold standard
for pain and other PROs measuring symptoms and
perceptions and that the “transition” question (global
rating of change) is often the only criterion available
for measuring change in PROs. However, there is an
ongoing debate on its validity and reliability [11,12]. It
is therefore still unclear whether the “transition” ques-
tion should be considered a gold, silver, or no standard
at all. Therefore the COSMIN panel proposed to con-
sider it a construct approach of responsiveness (com-
parable to construct validity) if the “transition”
question is used to assess responsiveness. In that case
it is recommended to define and test hypotheses e.g.
about the expected correlation between changes on the
instrument under study and the “transition’ question.
Moreover, it should not be the one and only hypoth-
esis to be tested. This is what we presented in our
example.
Similar as with effect sizes, COSMIN does not discard
the use of a “transition” question in the assessment of
responsiveness, but recommends to formulate and test
hypotheses about what correlations are to be expected.
Conclusion
We agree with dr Angst that the quantitative amount of
change is important for the clinician and should be easy
to comprehend. Therefore, the aim of a responsiveness
study is to show that the instrument indeed measures
the true amount of change that has occurred in the con-
struct of interest. According to the COSMIN panel, the
best design to show this is by testing hypotheses about
expected correlations or changes. Effect sizes and “tran-
sition” questions can be used, but they only provide evi-
dence for responsiveness if clear hypotheses about
expected changes are being tested.
The COSMIN approach for assessing responsiveness is
not more difficult than assessing validity. In fact, the
COSMIN panel proposed exactly the same approach
because responsiveness is defined as longitudinal
validity.
We acknowledge that the COSMIN panel has set high
standards. The main reason to do so is to improve
future studies on measurement properties, and to chal-
lenge readers of published studies to be critical when
interpreting results. It is not our intention to make all
research of the past 20 or 30 years irrelevant. We only
want to emphasize that because of new insights, we
could do better.
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